Prazosin to Prevent COVID-19 (PREVENT-COVID Trial)

Summary

The purpose of this study is to assess the efficacy and safety of prazosin to prevent cytokine storm syndrome and severe complications in hospitalized patients with Coronavirus disease 2019 (COVID-19).

Timeline

Start

2020-05-13

Primary completion

2022-03-31

Completion

2022-03-31

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment”

Drugs

Indications